Although the use of insulin analogs is generally associated with lower risks of hypoglycemia and improved patient experience, clinical studies did not find a significant difference in terms of glycosylated hemoglobin (HbA1c) levels—a proxy measure of glycemic control over the preceding 2 to 3 months—compared to regular insulin [34]. Here, INS is linked to Hypoglycemia.